A detailed history of Hhm Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hhm Wealth Advisors, LLC holds 6,311 shares of PFE stock, worth $187,184. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,311
Previous 5,773 9.32%
Holding current value
$187,184
Previous $160,000 10.0%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $13,589 - $15,924
538 Added 9.32%
6,311 $176,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $24,207 - $27,797
-935 Reduced 13.94%
5,773 $160,000
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $1,228 - $1,595
47 Added 0.71%
6,708 $193,000
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $14,793 - $17,292
461 Added 7.44%
6,661 $220,000
Q1 2023

May 02, 2023

BUY
$39.39 - $51.28 $2,875 - $3,743
73 Added 1.19%
6,200 $252,000
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $5,344 - $6,976
-128 Reduced 2.05%
6,127 $0
Q3 2022

Nov 04, 2022

SELL
$43.76 - $53.42 $18,816 - $22,970
-430 Reduced 6.43%
6,255 $274,000
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $9,445 - $11,199
203 Added 3.13%
6,685 $350,000
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $109,800 - $136,056
2,400 Added 58.79%
6,482 $336,000
Q4 2021

Feb 03, 2022

SELL
$41.32 - $61.25 $165 - $245
-4 Reduced 0.1%
4,082 $241,000
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $274 - $352
-7 Reduced 0.17%
4,086 $176,000
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $16,735 - $21,280
500 Added 13.92%
4,093 $151,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $7,842 - $9,200
247 Added 7.38%
3,593 $132,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $13,102 - $15,894
-435 Reduced 11.5%
3,346 $109,000
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $102,200 - $146,022
3,781 New
3,781 $123,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hhm Wealth Advisors, LLC Portfolio

Follow Hhm Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.